JPWO2021183790A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021183790A5 JPWO2021183790A5 JP2022554956A JP2022554956A JPWO2021183790A5 JP WO2021183790 A5 JPWO2021183790 A5 JP WO2021183790A5 JP 2022554956 A JP2022554956 A JP 2022554956A JP 2022554956 A JP2022554956 A JP 2022554956A JP WO2021183790 A5 JPWO2021183790 A5 JP WO2021183790A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- patient
- active ingredient
- fostamatinib
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 claims 7
- 208000007536 Thrombosis Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- GKDRMWXFWHEQQT-UHFFFAOYSA-N fostamatinib Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(NC=3N=C4N(COP(O)(O)=O)C(=O)C(C)(C)OC4=CC=3)C(F)=CN=2)=C1 GKDRMWXFWHEQQT-UHFFFAOYSA-N 0.000 claims 5
- 229950005309 fostamatinib Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 3
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 3
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 2
- 208000025721 COVID-19 Diseases 0.000 claims 2
- 208000033626 Renal failure acute Diseases 0.000 claims 2
- 201000011040 acute kidney failure Diseases 0.000 claims 2
- 206010003598 Atelectasis Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010011224 Cough Diseases 0.000 claims 1
- 239000003154 D dimer Substances 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 108010052295 fibrin fragment D Proteins 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 201000003144 pneumothorax Diseases 0.000 claims 1
- 230000003331 prothrombotic effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062988876P | 2020-03-12 | 2020-03-12 | |
| US62/988,876 | 2020-03-12 | ||
| US202063038570P | 2020-06-12 | 2020-06-12 | |
| US63/038,570 | 2020-06-12 | ||
| PCT/US2021/021951 WO2021183790A1 (en) | 2020-03-12 | 2021-03-11 | Method for treatment of covid-19-associated conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518356A JP2023518356A (ja) | 2023-05-01 |
| JPWO2021183790A5 true JPWO2021183790A5 (enExample) | 2024-03-21 |
Family
ID=77665493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554956A Pending JP2023518356A (ja) | 2020-03-12 | 2021-03-11 | Ｃｏｖｉｄ－１９関連状態の治療のための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12263180B2 (enExample) |
| EP (1) | EP4117728A4 (enExample) |
| JP (1) | JP2023518356A (enExample) |
| KR (1) | KR20220152293A (enExample) |
| CN (1) | CN115768474A (enExample) |
| AU (1) | AU2021234316A1 (enExample) |
| BR (1) | BR112022018235A2 (enExample) |
| CA (1) | CA3175089A1 (enExample) |
| IL (1) | IL296352A (enExample) |
| JO (1) | JOP20220218A1 (enExample) |
| MX (1) | MX2022011278A (enExample) |
| PE (1) | PE20230996A1 (enExample) |
| PH (1) | PH12022552539A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023194840A1 (en) | 2022-04-05 | 2023-10-12 | Unichem Laboratories Limited | Substituted tricyclic compounds and their use in covid-19 |
| CN116440117A (zh) * | 2023-06-14 | 2023-07-18 | 四川省医学科学院·四川省人民医院 | 甲磺酸萘莫司他在制备治疗肾损伤或肾功能不全药物中的应用 |
| CN116650507A (zh) * | 2023-06-28 | 2023-08-29 | 中国人民解放军军事科学院军事医学研究院 | 福它替尼在制备治疗放射性肺纤维化药物中的应用 |
| CN118649237A (zh) * | 2024-06-13 | 2024-09-17 | 高维医药(杭州)有限公司 | S蛋白或p4hb蛋白作为靶点在制备预防或治疗新冠感染相关性凝血病变的药物中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| ATE451104T1 (de) | 2002-07-29 | 2009-12-15 | Rigel Pharmaceuticals Inc | Verfahren zur behandlung oder pruvention von autoimmunkrankheiten mit 2,4-pyrimidindiamin- verbindungen |
| US8163902B2 (en) | 2006-11-21 | 2012-04-24 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| CA2704474C (en) | 2007-11-07 | 2016-04-26 | Rigel Pharmaceuticals, Inc. | Wet granulation using a water sequestering agent |
| WO2015116729A2 (en) | 2014-01-28 | 2015-08-06 | Emergent Product Development Seattle, Llc | Anti-cd37 antibody and anti-cd20 antibody combination therapy for treatment of b-cell malignancies and disorders |
| WO2016033416A1 (en) * | 2014-08-29 | 2016-03-03 | Board Of Regents, University Of Texas System | Bromodomain inhibitors for treating disease |
| GB202005890D0 (en) * | 2020-04-22 | 2020-06-03 | Aivivo Ltd | New uses |
-
2021
- 2021-03-11 CA CA3175089A patent/CA3175089A1/en active Pending
- 2021-03-11 AU AU2021234316A patent/AU2021234316A1/en active Pending
- 2021-03-11 CN CN202180034971.6A patent/CN115768474A/zh active Pending
- 2021-03-11 IL IL296352A patent/IL296352A/en unknown
- 2021-03-11 PH PH1/2022/552539A patent/PH12022552539A1/en unknown
- 2021-03-11 JP JP2022554956A patent/JP2023518356A/ja active Pending
- 2021-03-11 JO JOP/2022/0218A patent/JOP20220218A1/ar unknown
- 2021-03-11 KR KR1020227035071A patent/KR20220152293A/ko active Pending
- 2021-03-11 EP EP21768322.6A patent/EP4117728A4/en active Pending
- 2021-03-11 BR BR112022018235A patent/BR112022018235A2/pt unknown
- 2021-03-11 MX MX2022011278A patent/MX2022011278A/es unknown
- 2021-03-11 PE PE2022001945A patent/PE20230996A1/es unknown
- 2021-05-18 US US17/323,901 patent/US12263180B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021098728A5 (enExample) | ||
| JPWO2021183790A5 (enExample) | ||
| Scarbrough et al. | Pulmonary edema following postoperative laryngospasm: case reports and review of the literature | |
| JP2020516689A5 (enExample) | ||
| Holinger et al. | THE INFLUENCE OF EXPECTORANTS AND GASES: ON SPUTUM AND THE MUCOUS MEMBRANES OF THE TRACHEOBRONCHIAL TREE | |
| Uzieblo et al. | Incidence and significance of lobar atelectasis in thoracic surgical patients | |
| Hans et al. | Acute bilateral submandibular swelling following surgery in prone position | |
| Hazizaj et al. | Bronchospasm caused by neostigmine | |
| JP2002506009A (ja) | 呼吸器疾患および中耳炎の治療 | |
| Michalopoulos et al. | The incidence of adult respiratory distress syndrome in patients undergoing off-pump coronary artery bypass grafting surgery | |
| Waldbott | Bronchoscopic therapy in allergic asthma | |
| Kunwar et al. | A COMPARATIVE STUDY OF EFFICACY OF DEXAMETHASONE AND MgSO4 PREOPERATIVE NEBULISATION IN REDUCTION OF POST OPERATIVE SORE THROAT FOLLOWING GENERAL ANAESTHESIA | |
| Gray | Atelectasis as a complication of pulmonary lobectomy | |
| RU2600822C1 (ru) | Способ лечения хронического обструктивного бронхита | |
| Myerson | XIII Tuberculous Ulcerogranuloma of the Trachea and Bronchi | |
| Wolf et al. | Intraocular surgery with general anesthesia | |
| FARBER et al. | The rational approach in the use of bronchodilators in chronic respiratory disease | |
| Fernandez-Galinski et al. | Lethal adverse reaction during anaesthetic induction | |
| Gowrinath et al. | Acute total lung collapse in a woman with Acute Stroke and Atrial Fibrillation | |
| Harrington | The surgical treatment of bronchiectasis and lung abscess | |
| CARDON et al. | Acute suppurative bronchitis and bronchiolitis in chronic pulmonary disease: diagnosis and management | |
| JPWO2023107938A5 (enExample) | ||
| Apfelbach et al. | Recurrent postoperative atelectasis | |
| Zuege et al. | Management of acute respiratory failure in chronic obstructive pulmonary disease | |
| GÜL et al. | Comparison of the effects of pharyngeal packing and gastric aspiration with an orogastric tube on postoperative nausea, vomiting and sore throat in septorhinoplasty |